Effects of Lycium Barbarum Supplements on the Progression of Senile Cataract in Hong Kong Chinese Population
Primary Purpose
Lens Opacity
Status
Completed
Phase
Not Applicable
Locations
Hong Kong
Study Type
Interventional
Intervention
Starch
Lycium Barbarum
Sponsored by
About this trial
This is an interventional prevention trial for Lens Opacity
Eligibility Criteria
Inclusion Criteria:
- Unlikely to have cataract surgery within 3 years
- Presence of mild to moderate cataract in one or both eyes, graded by Lens Opacities Classification System III (LOCSIII).
- logMAR acuity equivalent to Snellen acuity of 20/63 or better
- no previous history and clinical signs of glaucoma by determining intraocular pressure using applanation Tonometry (no more than 22mmHg)
- no ocular anomalies: amblyopia, binocular anomalies, ocular trauma
- no history of eye surgery, laser treatment, iritis, retinal crystalline deposits, macular degeneration, or optic nerve diseases
- no extended use of systemic or ocular corticosteroid drugs
- no concurrent participation of other systemic or ocular drug intervention study
Exclusion Criteria:
- diabetes mellitus
- renal failure
- fat malabsorption syndrome
- intestinal surgery history
- chronic diarrhea
- alcoholism
- use of anticoagulants
- regular use of nutritional supplements such as multi-vitamin, mineral and other antioxidant supplements (including Omega-3)
Sites / Locations
- The Hong Kong Polytechnic University
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Placebo
Lycium Barbarum
Arm Description
Starch
Lycium Barbarum supplement
Outcomes
Primary Outcome Measures
Lens Opacity Classification System III (LOCSIII)
Secondary Outcome Measures
Visual Acuity
Full Information
NCT ID
NCT01142960
First Posted
June 10, 2010
Last Updated
May 10, 2016
Sponsor
The Hong Kong Polytechnic University
Collaborators
The Hong Kong Jockey Club Charities Trust
1. Study Identification
Unique Protocol Identification Number
NCT01142960
Brief Title
Effects of Lycium Barbarum Supplements on the Progression of Senile Cataract in Hong Kong Chinese Population
Official Title
Effects of Lycium Barbarum Supplements on the Progression of Senile Cataract in Hong Kong Chinese Population
Study Type
Interventional
2. Study Status
Record Verification Date
May 2016
Overall Recruitment Status
Completed
Study Start Date
November 2009 (undefined)
Primary Completion Date
April 2012 (Actual)
Study Completion Date
June 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Hong Kong Polytechnic University
Collaborators
The Hong Kong Jockey Club Charities Trust
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
With the rapid growing aging population, age-related eye diseases including cataract are becoming more prevalent. The demand for cataract surgery and post-surgical care posed enormous financial burdens to the government.
Lycium barbarum contains lutein and zeaxanthin which can filter the phototoxic blue light and neutralize the reactive oxygen species, thus provide a protective effect against cataract formation.
This study aims to determine the effects of Lycium barbarum Supplements on the progression of senile cataract in Hong Kong Chinese elderly.
Detailed Description
Please note that a manuscript for this study is being prepared. Detailed description will be provided after we come up with the final draft.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lens Opacity
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
238 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Placebo
Arm Type
Active Comparator
Arm Description
Starch
Arm Title
Lycium Barbarum
Arm Type
Experimental
Arm Description
Lycium Barbarum supplement
Intervention Type
Dietary Supplement
Intervention Name(s)
Starch
Intervention Description
1350mg/day
Intervention Type
Dietary Supplement
Intervention Name(s)
Lycium Barbarum
Intervention Description
1350mg/day
Primary Outcome Measure Information:
Title
Lens Opacity Classification System III (LOCSIII)
Time Frame
3 years
Secondary Outcome Measure Information:
Title
Visual Acuity
Time Frame
3 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
60 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Unlikely to have cataract surgery within 3 years
Presence of mild to moderate cataract in one or both eyes, graded by Lens Opacities Classification System III (LOCSIII).
logMAR acuity equivalent to Snellen acuity of 20/63 or better
no previous history and clinical signs of glaucoma by determining intraocular pressure using applanation Tonometry (no more than 22mmHg)
no ocular anomalies: amblyopia, binocular anomalies, ocular trauma
no history of eye surgery, laser treatment, iritis, retinal crystalline deposits, macular degeneration, or optic nerve diseases
no extended use of systemic or ocular corticosteroid drugs
no concurrent participation of other systemic or ocular drug intervention study
Exclusion Criteria:
diabetes mellitus
renal failure
fat malabsorption syndrome
intestinal surgery history
chronic diarrhea
alcoholism
use of anticoagulants
regular use of nutritional supplements such as multi-vitamin, mineral and other antioxidant supplements (including Omega-3)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Chi-wai Do, PhD
Organizational Affiliation
The Hong Kong Polytechnic University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Chea-su Kee, PhD
Organizational Affiliation
The Hong Kong Polytechnic University
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Hong Kong Polytechnic University
City
Hung Hom
State/Province
Kowloon
ZIP/Postal Code
0000
Country
Hong Kong
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Effects of Lycium Barbarum Supplements on the Progression of Senile Cataract in Hong Kong Chinese Population
We'll reach out to this number within 24 hrs